Peptide Therapy: What It Is, How It Works, and What the Research Says

Peptide therapy has quickly become one of the most talked-about areas in both functional and integrative medicine.

Researchers are actively studying peptides for applications involving metabolism, inflammation, gut health, tissue repair, immune regulation, recovery, and healthy aging. Some peptide-based therapies, like insulin and GLP-1 receptor agonists, are already backed by extensive clinical research and FDA approval. Others are earlier in the research process, but are generating significant scientific and clinical interest.

It’s important to note that the field is evolving rapidly, and not all peptide therapies carry the same level of evidence, safety data, or regulatory oversight.

In this article, I’ll walk through what peptides are, how they work, which peptides are generating the most attention, what the research currently supports, and where I think this field holds the most promise.

What Is Peptide Therapy?

Peptides are short chains of amino acids, the same building blocks that make up proteins. Your body naturally produces thousands of them to act as signaling molecules that help regulate processes like:

• Hormone release
• Metabolism
• Tissue repair
• Immune activity
• Inflammation
• Appetite and blood sugar regulation

Peptide therapy involves using synthetic or bioidentical versions of these compounds to influence specific biological pathways in a more targeted way.

One reason peptides have generated so much interest is that many of them appear to work with a relatively high degree of specificity. Rather than broadly stimulating an entire system, peptides often interact with very specific receptors and signaling pathways.

That targeted nature is part of what makes the field so exciting from a clinical perspective.

In recent years, peptide-based therapeutics have become one of the fastest-growing categories in pharmaceutical research. Between 2016 and 2024, more than 11% of the new chemical drugs approved by the FDA were synthetic peptides 1.

Peptides occupy a unique middle ground between small-molecule drugs and biologics. Compared to traditional pharmaceuticals, peptides often offer greater receptor specificity and fewer off-target effects. Compared to large biologic therapies, they are generally easier to engineer and modify for targeted applications.

How Do Peptides Work?

Peptides work by binding to receptors on cells and triggering specific biological responses.

Many peptides work by mimicking endogenous signaling molecules that the body already produces. After binding to specific cell-surface receptors, they trigger intracellular signaling cascades that influence metabolism, inflammation, tissue repair, hormone release, or immune activity.

The effect depends entirely on the peptide and the pathway being targeted.

Examples of peptides targeting specific pathways:

• GLP-1 receptor agonists mimic natural gut hormones involved in blood sugar regulation, appetite signaling, gastric emptying, and inflammatory pathways 2.
• Growth hormone-releasing peptides stimulate the body’s own release of human growth hormone (GH), also known as somatotropin, rather than replacing growth hormone directly 3.
• BPC-157 (Body Protection Compound) found in stomach juice appears to influence pathways involved in neurotransmitter production, collagen synthesis, and tissue repair 4.
• Immune-modulating peptides like thymosin alpha-1 may help regulate aspects of immune system activity and T-cell function 5.

Because peptides are made from amino acids, the body generally breaks them down relatively quickly. That’s one reason many peptides are typically administered by injection. Oral and topical delivery systems continue to improve for certain compounds, but this remains a developing process.

Why Do Peptides Have to Be Injected?

Peptides are short chains of amino acids that the body can quickly break down and eliminate. When taken by mouth, peptides must survive the digestive process, where stomach acid and digestive enzymes can degrade them before they reach their intended target 6. 

So, if a peptide is given as an injection rather than a pill, it can quickly reach the bloodstream and begin working in the body 7. 

That said, a major focus of current peptide research is finding better ways to improve stability, absorption, and tissue targeting. Researchers are actively studying peptide delivery strategies such as:

• PEGylation (attaching polyethylene glycol molecules to extend circulation time) 6
• Lipidation (adding lipid molecules to improve stability and absorption) 8
• Nanoparticle and liposomal delivery systems 6
• Enteric coatings and absorption enhancers for oral formulations 6
• Hydrogels, microneedles, and sustained-release systems 9

Some newer peptide drugs already incorporate these technologies. For example, the GLP-1 agonist Rybelsus is an oral tablet that works similarly to Ozempic and Wegovy, which are injected. This is because Rybelsus contains an absorption enhancer that improves uptake in the gastrointestinal tract, helping the medication reach the bloodstream 6. 

Most Common Peptides and What They’re Used For

Here is a practical overview of the peptides most frequently discussed and used in clinical and functional medicine contexts. Evidence levels vary considerably. I’ve tried to represent that accurately rather than overstating what the research supports.

GLP-1 Receptor Agonists: The Most Established Peptide Category

GLP-1 receptor agonists are currently the most evidence-supported peptide therapeutics in widespread clinical use. Originally developed for type 2 diabetes, they have since demonstrated substantial benefits for obesity, cardiovascular risk reduction, blood sugar regulation, and metabolic health 10.

What makes this category especially interesting is that the benefits appear to extend well beyond weight loss and glucose control. GLP-1 receptors are expressed throughout multiple organ systems, including the brain, cardiovascular system, gastrointestinal tract, pancreas, kidneys, and immune cells. 

Researchers are increasingly studying the broader physiologic effects of GLP-1 signaling on 11:

• Inflammation
• Immune regulation
• Cardiovascular protection
• Neurodegenerative disease pathways

Emerging evidence suggests GLP-1 receptor agonists may help modulate inflammatory signaling and immune activity through several mechanisms, including reductions in pro-inflammatory cytokines, improvements in metabolic inflammation, and effects on oxidative stress pathways 11.This growing understanding of GLP-1 biology is one reason researchers are now exploring potential applications in inflammatory, neurologic, and immune-mediated conditions beyond diabetes and obesity.

One area generating particular excitement is mast cell activation syndrome (MCAS). A landmark 2025 case series followed 47 patients with treatment-resistant MCAS and found that 89% experienced clinical benefit with GLP-1 receptor agonists, often within hours to days, across inflammatory, neurologic, gastrointestinal, and autonomic symptoms 12. We cover this in depth in our article: What Is MCAS? Mast Cell Activation Syndrome Explained.

Researchers are also studying potential neuroprotective effects of GLP-1 signaling, including possible roles in cognitive health, neuroinflammation, and neurodegenerative disease. Cardiovascular protection is another major area of interest, with large human trials showing reductions in cardiovascular events that appear to extend beyond improvements in blood sugar alone 13. 

Microdosed GLP-1 formulations are now available through KoraMD for those seeking anti-inflammatory benefits at lower doses compared to those used for weight management.

BPC-157: One of the Most Interesting Emerging Peptides

BPC-157, sometimes referred to as the “Body Protection Compound”, has generated substantial interest in both functional medicine and sports medicine communities because of its potential role in gut health, tissue repair, recovery, and inflammation support 14. 

Most of the evidence currently comes from animal and preclinical research, where BPC-157 has shown effects on pathways related to angiogenesis (growth of new capillaries from existing ones), collagen signaling, and tissue healing 14.

The findings are compelling enough that many clinicians are paying close attention to this peptide.

At the same time, robust human clinical trial data is still limited. There are no large-scale randomized controlled trials (RCTs) on BPC-157, which is important to acknowledge 14.

Somatostatin Analogs: Peptides in Cancer Research

Some peptide-based therapies are already used in oncology, while others remain experimental.

The most established examples are somatostatin analogs such as octreotide and lanreotide, which are used clinically in certain neuroendocrine tumors. Somatostatin is a hormone that your body produces to regulate other hormones and new cell production. 

Researchers are also actively studying: 

• Peptide-guided drug delivery systems 15
• Tumor-targeting peptides 15
• Peptide-based cancer vaccines 16

These are being designed to improve the precision of cancer therapies and stimulate anti-tumor immune responses 15 16. 

One reason peptides are attracting interest in oncology is their ability to bind selectively to receptors expressed on tumor cells. In theory, this may allow therapies to target cancer tissue more precisely while reducing damage to healthy tissue. Many of these approaches remain investigational, but peptide-based cancer therapeutics are considered one of the fastest-growing areas in pharmaceutical research 7 9.

CJC-1295 + Ipamorelin: Growth Hormone Support

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone secretagogue that acts through the ghrelin (GHS-R1a) receptor. Because these peptides stimulate human growth hormone (GH) release through distinct yet complementary pathways, they are frequently used together in peptide protocols to enhance the body’s endogenous production of GH. Preclinical and mechanistic research suggests that simultaneous activation of the GHRH and GHS-R pathways can produce a greater GH response than either pathway alone. Ipamorelin is also notable for its selectivity, as it appears to have minimal effects on cortisol and prolactin compared with earlier GH secretagogue medications 17 18.

This category has attracted interest for:

• Recovery
• Sleep quality
• Body composition
• Exercise recovery
• Age-related decline in growth hormone production

Sermorelin has the longest clinical track record within this category and has historically been used in more conventional medical settings 19.

CJC-1295 and Ipamorelin are newer and have become increasingly popular in functional medicine and longevity-focused practices, but they lack long-term safety data and FDA approval. 

One reason some clinicians prefer these peptides over direct growth hormone administration is that they stimulate the body’s own physiologic signaling pathways rather than replacing growth hormone outright. Human studies confirm that CJC-1295 raises HGH and IGF-1 (insulin-like growth factor) levels 17 20.

Still, long-term safety data remains limited compared to more established therapies, and these peptides should be approached thoughtfully and with appropriate monitoring.

Thymosin Alpha-1: Immune Function Peptides

Thymosin alpha-1 is an immune-modulating peptide involved in T-cell development and immune regulation 21.

Thymosin alpha-1 has been studied in areas like:

• Chronic viral infections 22
• Immune programming 23
• Immune resilience 24
• Inflammatory conditions 25

This is another peptide category that I think deserves attention moving forward, particularly as research continues to explore the relationship among immune signaling, chronic inflammation, and overall health.

GHK-Cu: Skin, Wound Healing, and Collagen

GHK-Cu (copper peptide) has a well-documented track record in topical applications for skin repair, collagen stimulation, and wound healing 26 27. While it’s widely used in topical skincare, its injectable use has been studied less. For patients interested in skin and connective tissue support, topical GHK-Cu currently has the most credible evidence base 28.

What Can Peptide Therapy Help With?

Based on current evidence and clinical interest, peptide therapy may have potential applications involving 7:

• Metabolic health and blood sugar regulation
• Appetite and weight management
• Gut health and mucosal repair
• Exercise recovery and body composition
• Soft tissue recovery
• Sleep quality
• Immune regulation
• Healthy aging support
• Skin and collagen health
• Cancer treatment

Peptide therapy is not a first-line or standalone treatment for most conditions. It works best as part of a comprehensive care plan that addresses foundational health factors: diet, gut health, sleep, stress, and appropriate diagnostics.

Safety, Regulation, and What to Watch Out For

The regulatory landscape for peptide therapy in the United States has shifted significantly since 2023, and patients need to understand what’s changed.

The FDA Compounding Situation

Between 2023 and 2024, the FDA moved 19 popular peptides, including BPC-157, CJC-1295, Ipamorelin, and thymosin alpha-1, to a Category 2 list. When a substance is on the Category 2 list, that means the FDA has determined that there are significant safety risks. Here, they cited insufficient human safety data and concerns about immunogenicity (the ability of a substance to alter the immune system). This effectively banned compounding pharmacies from preparing these substances for patients 29. 

Following pushback from the compounding community, a September 2024 settlement required the FDA to submit several key peptides, including CJC-1295, Ipamorelin, and thymosin alpha-1, for formal review by the Pharmacy Compounding Advisory Committee rather than issuing a unilateral ban. That review process is ongoing as of 2026 30.

The practical implication here: The availability of specific peptides through licensed compounding pharmacies may change. Working with a clinician who actively tracks this landscape is important.

The Real Risk: Unregulated Sources

The greater clinical risk often isn’t the peptides themselves; it’s where they come from. FDA testing of peptides sold online has found that a significant proportion contain incorrect dosages or undeclared ingredients. Products sold as “research chemicals” are not the same as peptides compounded by a licensed pharmacy under physician supervision, even when they share the same name.

Self-administering peptides purchased online carries real risk of: 

• Contamination
• Inaccurate dosing
• Unknown impurities
• No clinical oversight to catch contraindications or adverse reactions

Although peptides are composed of amino acids and often mimic naturally occurring signaling molecules, this does not automatically guarantee safety. Potent biological effects, off-target signaling, dosing variability, and immunogenicity remain important considerations.

General Safety Considerations

• Most peptides, when properly sourced and used under clinical supervision, are generally well tolerated.
• Injection site reactions are among the most commonly reported side effects.
• Growth hormone-stimulating peptides may influence insulin sensitivity, fluid retention, and hormone signaling with long-term use 31.
• Immunogenicity, an unintended immune response to a peptide, is a recognized risk, particularly with repeated administration 1.
• Peptide therapy is generally not considered appropriate during pregnancy or for patients with active malignancy without specialist guidance.
• Oral peptide delivery remains an emerging research area because bioavailability is variable, and many oral formulations rely on absorption enhancers.

How to Know If Peptide Therapy Is Right for You

Peptide therapy is most likely to be worthwhile when:

• You have a specific, well-defined clinical goal (gut healing, GH optimization, metabolic support) rather than a general desire to “feel better”.
• Foundational health factors, such as diet, gut health, sleep, and stress management, are already being addressed.
• You’re working with a clinician who can match the right peptide to your individual labs, history, and goals.
• You’re using peptides obtained through a licensed compounding pharmacy with proper oversight.
• You have realistic expectations: Peptides are adjuncts, not shortcuts.

In our clinic, peptide therapy is considered contextually as part of a comprehensive functional medicine evaluation, not as an isolated intervention. The most important work is almost always foundational: Start with optimizing gut health, diet, sleep, and reducing inflammatory burden. Peptides can add meaningful benefits on top of that foundation, for the right patient.

Future Directions of Peptide Therapy

Peptide therapeutics are evolving rapidly, and many researchers believe the field is still in its early stages. While some peptide-based therapies, particularly GLP-1 receptor agonists, are already well established in mainstream medicine, newer generations of peptides are being engineered to be more targeted, longer-lasting, and easier to deliver. Major areas of innovation include oral peptide formulations 6, nanoparticle delivery systems 9, sustained-release technologies 32, hydrogels 9 33, and microneedle systems 9 designed to improve absorption and reduce the need for injections. 

Researchers are also exploring peptide-guided nanoparticles (15), peptide-drug conjugates (15), and peptide-based vaccines (16) that may improve the precision of cancer treatment while minimizing damage to healthy tissue. Beyond oncology, peptides are being investigated for personalized medicine 7, antimicrobial therapies 34, regenerative medicine 35, wound healing and tissue repair 7, and immune modulation 7. Because peptides can interact very selectively with receptors and signaling pathways, future therapies may become increasingly tailored to an individual’s genetics, metabolic profile, immune function, and disease characteristics. 

At the same time, much of this research is exploratory. Many peptide therapies still lack large-scale human clinical trials, long-term safety data, or standardized regulatory pathways. The science is promising, but separating well-supported therapies from speculative claims remains essential. In my view, the greatest potential for peptide therapy lies not as a shortcut or a standalone solution, but as part of a personalized, precision-based approach to medicine that still prioritizes foundational health factors such as diet, gut health, sleep, movement, and reducing the inflammatory burden.

Bottom Line on Peptide Therapy

Peptide therapy represents a genuinely interesting and evolving area of functional and integrative medicine. The biology is compelling, some of the clinical applications are well-supported, and the field is moving toward more rigorous investigation.

But it also requires clear-eyed thinking. The evidence base is uneven, the regulatory environment is shifting, and the online market is rife with unregulated products and overstated claims. Peptide therapy is not a shortcut, and it’s not right for everyone.

For patients who are already doing the foundational work, such as gut health, diet, sleep, reducing inflammatory burden, and who have a specific clinical goal that maps to a well-characterized peptide, it can be a meaningful part of a personalized care plan.

If you’re curious whether peptide therapy makes sense for your situation, we’re here to help you think through it. Learn more about how to become a patient at the Ruscio Institute for Functional Medicine, and let’s start with the full picture.